117
Participants
Start Date
July 1, 2020
Primary Completion Date
April 22, 2021
Study Completion Date
August 26, 2021
LY3016859
LY3016859 given IV.
Placebo
Placebo given IV.
Altoona Center For Clinical Research, Duncansville
Clinical Research Center of Reading,LLC, Wyomissing
PharmQuest, Greensboro
Coastal Carolina Research Center, North Charleston
Synexus Clinical Research US, Inc - Orlando, The Villages
Synexus - US, Orlando
Suncoast Research Group, Miami
Gold Coast Research, Plantation
Synexus - US, Pinellas Park
Renstar Medical Research, Ocala
Simon Williamson Clinic, Birmingham
Aventiv Research Inc, Columbus
Rapid Medical Research, Cleveland
Synexus - Cincinnati, Cincinnati
Great Lakes Research Group, Inc., Bay City
Synexus Clinical Research, Chicago
Northwestern University, Chicago
StudyMetrix Research, City of Saint Peters
Cotton O'Neil Infusion Center, Topeka
Synexus - US, Omaha
Synexus - US, Dallas
Synexus - US, San Antonio
Synexus - US, Murray
Synexus- Chandler, Chandler
Synexus Clinical Research - Glendale, Glendale
Artemis Institute for Clinical Research, San Diego
Artemis Institute for Clinical Research, Riverside
Irvine Clinical Research Center, Irvine
Rainier Clinical Research Center, Renton
ActivMed Practices and Research, Methuen
MedVadis Research Corporation, Waltham
Northwest Clinical Research Center, Bellevue
Latin Clinical Trial Center, San Juan
Eli Lilly and Company
INDUSTRY